Kun Tang

4.6k total citations
129 papers, 3.0k citations indexed

About

Kun Tang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Kun Tang has authored 129 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 35 papers in Molecular Biology and 26 papers in Cancer Research. Recurrent topics in Kun Tang's work include Cancer-related molecular mechanisms research (17 papers), MicroRNA in disease regulation (15 papers) and Nanoplatforms for cancer theranostics (13 papers). Kun Tang is often cited by papers focused on Cancer-related molecular mechanisms research (17 papers), MicroRNA in disease regulation (15 papers) and Nanoplatforms for cancer theranostics (13 papers). Kun Tang collaborates with scholars based in China, United States and Australia. Kun Tang's co-authors include Zhangqun Ye, Hua Xu, Zhiqiang Chen, Haibing Xiao, Xia Ding, Heng Li, Haoran Liu, Yu Gan, Kehua Jiang and Xiaoqi Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Kun Tang

118 papers receiving 3.0k citations

Peers

Kun Tang
Comparison fields: 5 of 137
  • Molecular Biology 1.5k
  • Cancer Research 1.1k
  • Pulmonary and Respiratory Medicine 918
  • Surgery 459
  • Oncology 313
Bin Zhao China
Linda Sugar Canada
Zhangqun Ye China
Won Tae Kim South Korea
Jinbo Chen China
Ning Zhang China
Bin Sun China
Joseph Wagner United States
Kai Cui China
Wenqi Wu China
Bin Zhao China View profile →
Citations per field, relative to Kun Tang
Kun Tang · 1×
Citations per year, relative to Kun Tang
Kun Tang · 1×

Countries citing papers authored by Kun Tang

Since Specialization
Citations

This map shows the geographic impact of Kun Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Tang more than expected).

Fields of papers citing papers by Kun Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Tang. The network helps show where Kun Tang may publish in the future.

Co-authorship network of co-authors of Kun Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Tang. A scholar is included among the top collaborators of Kun Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Tang. Kun Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Genetically engineered hybrid membrane-coated nanoparticles enable triple activation of dendritic cells for synergistic bladder cancer immunotherapy Chemical Engineering Journal Jian Wu, Wen Deng et al. 0
2 METTL3 promotes an immunosuppressive microenvironment in bladder cancer via m6A-dependent CXCL5/CCL5 regulation Journal for ImmunoTherapy of Cancer Jian Wu, Qiu Huang et al. 2
3 Comprehensive Characterization of Aroma Compounds in Four Different Varieties of Cigar Tobacco Leaves from China Using HS-SPME-GC × GC-TOF-MS Combined with Flavor Profiling ACS Omega Yutong Liu, Yijing Luo et al. 0
4 Reprogramming of Glucose Metabolism by Nanocarriers to Improve Cancer Immunotherapy: Recent Advances and Applications International Journal of Nanomedicine Hongming Liu, Xiaolong Chen et al. 3
5 ROS-responsive resiquimod prodrug nanoparticles for macrophage reprogramming and enhanced immune checkpoint inhibitor therapy in bladder cancer Biomaterials Rui Geng, Kun Tang et al. 0
6 A review of laser-assisted cutting of hard and brittle materials: Tools, devices and mechanisms Optics & Laser Technology Kun Tang et al. 0
7 Ficolin-1 ameliorates pulmonary fibrosis via directly binding to TGF-β1 Journal of Translational Medicine Pengfei Gao, Yanjiao Lu et al. 1
8 Recent Advances in Nanomaterials for the Treatment of Acute Kidney Injury ACS Applied Materials & Interfaces Ye Tao, Yu He et al. 15
9 Nanoparticles targeting the adenosine pathway for cancer immunotherapy Journal of Materials Chemistry B Qing Wang, Yanlong Zhang et al. 3
10 The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts International Journal of Nanomedicine Yue Ge, Yu He et al. 15
11 Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy Nanoscale Wen Deng, He Yu et al. 12
12 Antioxidant nanozymes in kidney injury: mechanism and application Nanoscale Jian Wu, An Zhang et al. 16
13 Second near-infrared nanomaterials for cancer photothermal immunotherapy Materials Today Advances Jian Wu, Xiao Liu et al. 13
14 Circular RNAs in prostate cancer: Biogenesis, biological functions, and clinical significance Molecular Therapy — Nucleic Acids Xiao Liu, Xia Ding et al. 24
15 Comparison of two techniques for the management of 2–3 cm lower pole renal calculi in obese patients World Journal of Urology Xiao Liu, Xia Ding et al. 14
16 Expression profiles, biological functions and clinical significance of circRNAs in bladder cancer Molecular Cancer Xiaoqi Yang, Tao Ye et al. 130
17 Comparison of contrast-enhanced ultrasound versus conventional ultrasound-guided percutaneous nephrolithotomy in patients with nondilated collecting system: a randomized controlled trial European Radiology Xia Ding, Ejun Peng et al. 8
18 IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR Pathway in Colorectal Cancer Oxidative Medicine and Cellular Longevity Lei Zhang, Wen Liu et al. 118
19 Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis Disease Markers Haoran Liu, Tao Ye et al. 15
20 Pseudogene PTENP1 Functions as a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma Progression Molecular Cancer Therapeutics Yu Gan, Weimin Yao et al. 166

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Zhao Breakdown of academic impact, for papers by Linda Sugar Breakdown of academic impact, for papers by Zhangqun Ye Breakdown of academic impact, for papers by Won Tae Kim Breakdown of academic impact, for papers by Jinbo Chen Breakdown of academic impact, for papers by Ning Zhang Breakdown of academic impact, for papers by Bin Sun Breakdown of academic impact, for papers by Joseph Wagner Breakdown of academic impact, for papers by Kai Cui Breakdown of academic impact, for papers by Wenqi Wu
Rankless by CCL
2026